3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other neoplasm
1
Gastrointestinal
1
Conditions
Rectal Neoplasms
1
Prostatic Neoplasms
1
Precancerous Conditions
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Adenomatous Polyps
1
Interventions
Polymerase Chain Reaction
4
Selenium
3
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
3
fludarabine phosphate
2
fludarabine
2
Whole-Body Irradiation
2
Vitamin E
2
Tacrolimus
2
Radiotherapy, Intensity-Modulated
2
Peripheral Blood Stem Cell Transplantation
2
Patient Reported Outcome Measures
2
Mycophenolic Acid
2
Mesna
2
Melphalan
2
Light Coagulation
2
Cytogenetic Analysis
2
Cyclophosphamide
2
Cisplatin
2
Cetuximab
2
Busulfan
2
alpha-Tocopherol
1
Watchful Waiting
1
Vaginal Smears
1
Soybean Proteins
1
Rosuvastatin Calcium
1
Paclitaxel
1
Moxifloxacin
1
Morphine
1
Microarray Analysis
1
In Situ Hybridization, Fluorescence
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
NETWORK
×
Precancerous Conditions
×
alpha-Tocopherol
×
Clear all
NCT00706121
2019-12-16
ACP
SWOG Cancer Research Network
Phase 3
Completed
8,094 enrolled
23 charts